These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23866673)

  • 1. Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial.
    O'Meara E; Mielniczuk LM; Wells GA; deKemp RA; Klein R; Coyle D; Mc Ardle B; Paterson I; White JA; Arnold M; Friedrich MG; Larose E; Dick A; Chow B; Dennie C; Haddad H; Ruddy T; Ukkonen H; Wisenberg G; Cantin B; Pibarot P; Freeman M; Turcotte E; Connelly K; Clarke J; Williams K; Racine N; Garrard L; Tardif JC; DaSilva J; Knuuti J; Beanlands R;
    Trials; 2013 Jul; 14():218. PubMed ID: 23866673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine versus selective cardiac magnetic resonance in non-ischemic heart failure - OUTSMART-HF: study protocol for a randomized controlled trial (IMAGE-HF (heart failure) project 1-B).
    Paterson I; Wells GA; Ezekowitz JA; White JA; Friedrich MG; Mielniczuk LM; O'Meara E; Chow B; DeKemp RA; Klein R; Dennie C; Dick A; Coyle D; Dwivedi G; Rajda M; Wright GA; Laine M; Hanninen H; Larose E; Connelly KA; Leong-Poi H; Howarth AG; Davies RA; Duchesne L; Yla-Herttuala S; Saraste A; Farand P; Garrard L; Tardif JC; Arnold M; Knuuti J; Beanlands R; Chan KL
    Trials; 2013 Oct; 14():332. PubMed ID: 24119686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does imaging-guided selection of patients with ischemic heart failure for high risk revascularization improve identification of those with the highest clinical benefit?: Imaging-guided selection of patients with ischemic heart failure for high-risk revascularization improves identification of those with the highest clinical benefit.
    Mielniczuk LM; Beanlands RS
    Circ Cardiovasc Imaging; 2012 Mar; 5(2):262-70; discussion 270. PubMed ID: 22438424
    [No Abstract]   [Full Text] [Related]  

  • 4. Imaging heart failure: current and future applications.
    Paterson I; Mielniczuk LM; O'Meara E; So A; White JA
    Can J Cardiol; 2013 Mar; 29(3):317-28. PubMed ID: 23439018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How.
    Liga R; Colli A; Taggart DP; Boden WE; De Caterina R
    J Am Heart Assoc; 2023 Mar; 12(6):e026943. PubMed ID: 36892041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viability by MRI or PET would not have changed the results of the STICH trial.
    Asrani NS; Chareonthaitawee P; Pellikka PA
    Prog Cardiovasc Dis; 2013; 55(5):494-7. PubMed ID: 23518378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy.
    Bose A; Kandala J; Upadhyay GA; Riedl L; Ahmado I; Padmanabhan R; Gewirtz H; Mulligan LJ; Singh JP
    J Cardiovasc Electrophysiol; 2014 May; 25(5):507-513. PubMed ID: 24350650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Current Role of Viability Imaging to Guide Revascularization and Therapy Decisions in Patients With Heart Failure and Reduced Left Ventricular Function.
    Kandolin RM; Wiefels CC; Mesquita CT; Chong AY; Boland P; Glineur D; Sun L; Beanlands RS; Mielniczuk LM
    Can J Cardiol; 2019 Aug; 35(8):1015-1029. PubMed ID: 31376903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease.
    Mc Ardle B; Shukla T; Nichol G; deKemp RA; Bernick J; Guo A; Lim SP; Davies RA; Haddad H; Duchesne L; Hendry P; Masters R; Ross H; Freeman M; Gulenchyn K; Racine N; Humen D; Benard F; Ruddy TD; Chow BJ; Mielniczuk L; DaSilva JN; Garrard L; Wells GA; Beanlands RS;
    Circ Cardiovasc Imaging; 2016 Sep; 9(9):. PubMed ID: 27609816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF).
    Rezende PC; Hueb W; Bocchi EA; Farkouh M; Junior CVS; Lima EG; Silva EER; Dallan LAO; Gaiotto FA; Garzillo CL; Rochitte CE; Nomura CH; Scudeler TL; Soares PR; Jatene FB; Ramires JAF; Filho RK
    Trials; 2020 Apr; 21(1):337. PubMed ID: 32299458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viability by MRI or PET would have changed the results of the STICH trial.
    Srichai MB; Jaber WA
    Prog Cardiovasc Dis; 2013; 55(5):487-93. PubMed ID: 23518377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF).
    Hou YZ; Wang S; Zhao ZQ; Wang XL; Li B; Soh SB; Mao JY
    Trials; 2013 May; 14():138. PubMed ID: 23672353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(8):1-64. PubMed ID: 23074411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Functional Testing for Ischemia and Viability Guide Revascularization?
    Mielniczuk LM; Toth GG; Xie JX; De Bruyne B; Shaw LJ; Beanlands RS
    JACC Cardiovasc Imaging; 2017 Mar; 10(3):354-364. PubMed ID: 28279384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revascularization in heart failure in the post-STICH era.
    Jha S; Flamm SD; Kwon DH
    Curr Heart Fail Rep; 2013 Dec; 10(4):365-72. PubMed ID: 24142670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronization therapy and bone marrow cell transplantation in patients with ischemic heart failure and electromechanical dyssynchrony: a randomized pilot study.
    Pokushalov E; Romanov A; Corbucci G; Prohorova D; Chernyavsky A; Larionov P; Terekhov I; Artyomenko S; Kliver E; Shirokova N; Karaskov A; Dib N
    J Cardiovasc Transl Res; 2011 Dec; 4(6):767-78. PubMed ID: 21547598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPECT and PET in ischemic heart failure.
    Angelidis G; Giamouzis G; Karagiannis G; Butler J; Tsougos I; Valotassiou V; Giannakoulas G; Dimakopoulos N; Xanthopoulos A; Skoularigis J; Triposkiadis F; Georgoulias P
    Heart Fail Rev; 2017 Mar; 22(2):243-261. PubMed ID: 28150111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial viability as integral part of the diagnostic and therapeutic approach to ischemic heart failure.
    Bax JJ; Delgado V
    J Nucl Cardiol; 2015 Apr; 22(2):229-45. PubMed ID: 25733105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial.
    Abraham A; Nichol G; Williams KA; Guo A; deKemp RA; Garrard L; Davies RA; Duchesne L; Haddad H; Chow B; DaSilva J; Beanlands RS;
    J Nucl Med; 2010 Apr; 51(4):567-74. PubMed ID: 20237039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.